CARBOPLATIN "EBEWE" 10 mg/ml Concentrate for Solution for Infusion

Carboplatin "Ebewe" is a platinum-based antineoplastic agent used in the treatment of various types of cancer. It is provided as a concentrate for solution for infusion, designed for intravenous administration by healthcare professionals. This potent chemotherapy drug works by interfering with the DNA of cancer cells, inhibiting their growth and replication, leading to cell death.

This product is part of a crucial therapeutic regimen in oncology, tailored to combat aggressive cancers. Its use requires careful medical supervision and monitoring to ensure efficacy and manage potential side effects.

Benefits of Use

• Effective in treating a range of cancers including ovarian cancer, lung cancer, head and neck cancer, and testicular cancer.
• Often used as a key component in combination chemotherapy regimens, enhancing overall treatment outcomes.
• Administered intravenously, allowing for precise dosing and systemic delivery to target cancer cells throughout the body.

How to Use

Carboplatin "Ebewe" must be administered strictly by qualified healthcare professionals experienced in oncology and the use of antineoplastic agents.

1. The concentrate must be diluted before use with appropriate infusion solutions (e.g., 5% Dextrose Injection or 0.9% Sodium Chloride Injection) to the prescribed concentration.
2. Administer as an intravenous infusion over a specified period, typically 15 minutes to 1 hour or longer, as determined by the physician.
3. The dosage and duration of treatment are highly individualized based on the patient's body surface area, renal function, type of cancer, and other factors, including prior chemotherapy.
4. Close monitoring of blood counts (especially platelets), kidney function, and neurological status is essential throughout the treatment course.
5. Strict aseptic technique must be followed during preparation and administration to prevent contamination.

Caution & Warnings

• Carboplatin can cause severe myelosuppression (bone marrow suppression), leading to a reduction in white blood cells, red blood cells, and platelets. This requires frequent monitoring of blood counts.
• Patients may experience nausea, vomiting, and other gastrointestinal side effects. Prophylactic antiemetics are often prescribed.
• Potential for nephrotoxicity (kidney damage) and ototoxicity (hearing impairment). Renal function and hearing should be monitored.
• Peripheral neuropathy (nerve damage) may occur, manifesting as numbness, tingling, or weakness, particularly in patients previously treated with cisplatin.
• Hypersensitivity reactions, including anaphylaxis, can occur, especially with subsequent doses. Emergency medical equipment and personnel should be readily available.
• Carboplatin is contraindicated in patients with severe bone marrow depression, severe renal impairment, or a history of severe allergic reactions to carboplatin or other platinum-containing compounds.
• This medication should not be used during pregnancy or lactation due to potential harm to the fetus or infant. Women of childbearing potential should use effective contraception during and after treatment.
• Avoid contact with skin and mucous membranes. In case of accidental contact, wash thoroughly with soap and water.
• Handle and dispose of according to local regulations for cytotoxic drugs.

Ingredients

Active Ingredient: Carboplatin

Excipients: Water for injection (and possibly others as per specific formulation, but generally minimal for an injectable concentrate).

Product Details

Carboplatin "Ebewe" 10 mg/ml Concentrate for Solution for Infusion is typically presented as a clear, colorless to pale yellow solution in a glass vial. Each 15 ml vial contains 150 mg of Carboplatin. It is a sterile, pyrogen-free solution intended solely for intravenous use after appropriate dilution.